Literature DB >> 11883935

Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors.

Tiziana Parisi1, Alessandra Pollice, Antonio Di Cristofano, Viola Calabrò, Girolama La Mantia.   

Abstract

The human ARF/INK4a locus encodes two cell cycle inhibitors, p16(INK4a) and p14(ARF), by using separate promoters. A variety of mitogenic stimuli upregulate ARF but a direct modulation at the transcriptional level has been reported only for E2F-1. We show here that the ARF promoter is strongly responsive also to E2F2 and E2F3, thus providing a strong support to their suggested role in the induction of apoptosis. Through the usage of both deletion mutants and/or site-directed mutants, we surprisingly found that none of the four putative E2F consensus sites is strictly necessary for the upregulation of ARF expression, as a minimal deletion mutant, lacking all the putative E2F binding sites, is still transactivated by E2F. Moreover, our data suggest that the ARF promoter is regulated by E2F through both direct binding to the promoter sequences and indirectly, probably by being tethered to the ARF promoter by Sp1-like factors. (C)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883935     DOI: 10.1006/bbrc.2002.6591

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells.

Authors:  Ran Elkon; Chaim Linhart; Roded Sharan; Ron Shamir; Yosef Shiloh
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

2.  EAPP, a novel E2F binding protein that modulates E2F-dependent transcription.

Authors:  Michael Novy; Regina Pohn; Peter Andorfer; Tina Novy-Weiland; Barbara Galos; Ludwig Schwarzmayr; Hans Rotheneder
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

3.  Aberrant Expression of p14ARF in Human Cancers: A New Biomarker?

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Tumor Microenviron       Date:  2019-02-04

4.  Distinct E2F-mediated transcriptional program regulates p14ARF gene expression.

Authors:  Hideyuki Komori; Mitsuru Enomoto; Masataka Nakamura; Ritsuko Iwanaga; Kiyoshi Ohtani
Journal:  EMBO J       Date:  2005-10-06       Impact factor: 11.598

5.  Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.

Authors:  Thirupandiyur S Udayakumar; Radka Stoyanova; Paul Hachem; Mansoor M Ahmed; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-01       Impact factor: 7.038

6.  Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

Authors:  Aaron Aslanian; Phillip J Iaquinta; Raluca Verona; Jacqueline A Lees
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

7.  Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF.

Authors:  Aram Ko; Su Yeon Han; Chel Hun Choi; Hanbyoul Cho; Min-Sik Lee; Soo-Youl Kim; Joon Seon Song; Kyeong-Man Hong; Han-Woong Lee; Stephen M Hewitt; Joon-Yong Chung; Jaewhan Song
Journal:  Cell Death Differ       Date:  2018-02-22       Impact factor: 15.828

8.  ARF-induced downregulation of Mip130/LIN-9 protein levels mediates a positive feedback that leads to increased expression of p16Ink4a and p19Arf.

Authors:  J Song; R Sandoval; M A Pilkinton; X Tian; P Raychaudhuri; O R Colamonici
Journal:  Oncogene       Date:  2010-01-18       Impact factor: 9.867

9.  Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma.

Authors:  Prabha B Mishra; Aurelio S Lobo; Kalpana S Joshi; Maggie J Rathos; Gopinath A Kumar; Muralidhara Padigaru
Journal:  J Transl Med       Date:  2013-02-18       Impact factor: 5.531

10.  Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family.

Authors:  Viola Calabrò; Gelsomina Mansueto; Raffaela Santoro; Antonio Gentilella; Alessandra Pollice; Pamela Ghioni; Luisa Guerrini; Girolama La Mantia
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.